Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103

By Ruddy Kathryn   O’Neill Anne   Miller Kathy   Schneider Bryan   Baker Emily   Sparano Joseph   Dang Chau   Northfelt Donald   Sledge George   Partridge Ann  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 591-597

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

By Cameron David   Douglas Sharon   Brown Janet   Anderson Richard  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 805-814

Springer Publishing Company

Access to resources Recommend Favorite

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

By Okanami Yuko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 182-188

Springer Publishing Company

Access to resources Recommend Favorite

The Clinical Outcome of Chemotherapy-Induced Amenorrhea in Premenopausal Young Patients with Breast Cancer with Long-Term Follow-up

By Jung Minkyu  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3259-3268

Springer Publishing Company

Access to resources Recommend Favorite